Ynsect, a French company specializing in insect biotechnology, raised €5.5m in funding.
Backers included New Protein Capital, and current investors Emertec Gestion and Demeter Partners.
The company intends to use the funds to advance its solution, strengthen its position internationally, particularly in Asia, accelerate its R&D work in a new 1700m² facility at Genopole in Evry, begin industrializing its processes and continue its strategy to develop partnerships with manufacturing companies abroad.
Founded in 2011 by Antoine Hubert, Jean-Gabriel Levon, Fabrice Berro and Alexis Angot, Ynsect has developed Entoraffinerie© for the nutritional and green chemistry markets.
The company has already implemented major R&D programs in collaboration with key academic and research institutions in France and Europe (CEA, INRA, CNRS, IFREMER, AgroParisTech, IRSTEA, Wageningen University etc.). It is supported by Bpifrance and the Ile-de-France Region.
FinSMEs
05/01/2015